Temporary access
May provide temporary SKYRIZI product at no cost for eligible commercially insured patients whose coverage is delayed or denied.
What it does
Uses the Skyrizi Complete enrollment and prescription process to evaluate ongoing-therapy or temporary free-product options while the clinic continues required coverage work.
Open official program pagePotentially available to eligible commercially insured patients with a documented coverage delay or denial and a valid SKYRIZI prescription.
Government program exclusions: Medicare, Medicaid, TRICARE, VA, DoD, Other federal or state healthcare programs
Complete all applicable sections and submit through an AbbVie-authorized channel.
Open documentSubmit plan correspondence or other requested evidence to the hub.
Continue plan-required prior authorization, exception, or appeal activity while temporary support is used.
The clinic submits the combined form and documentation of the commercial coverage delay or denial. The hub determines whether the patient qualifies for temporary product support.
Best for: Services requiring clinical information, a prescription, or prescriber attestation
Patient completes demographics and the authorization/consent section of the official form.
Owner: Patient
Have ready: Contact information, Signature and date
Prescriber And Clinic Staff, Skyrizi Complete, Patient, Health Plan, Authorized Pharmacy
Skyrizi Complete
Enrollment, insurance, savings, infusion, and treatment support.
Phone support; 24/7 chat is advertised on the official program page.
Official combined enrollment and prescription form; clinic submission is required for prescription and access services.
Describes savings, insurance and specialty-pharmacy support, Nurse Ambassadors, the Complete App, and the program phone number.
Prescriber completes the prescription, clinical, insurance, and service-selection sections and attaches supporting records.
Owner: Prescriber or clinic staff
Have ready: Signed form, Insurance cards, Prescription, Prior-authorization or denial documentation
After enrollment: The hub communicates approval, pharmacy or shipment details, and any ongoing coverage-work requirements to the clinic and patient.
If there is a problem: The clinic should call the hub if a dose is approaching and the plan decision or shipment remains unresolved.
